Baillie Gifford add Denali Therapeutics Inc.
Baillie Gifford add $388.8M of disclosed value in Denali Therapeutics Inc..
Signal
Investor Move
Action
Add
Capital
$388.8M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.